GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Cash Flow from Financing

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Cash Flow from Financing : $0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2023, AfterNext HealthTech Acquisition paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, AfterNext HealthTech Acquisition spent $0.00 Mil on financial activities for the three months ended in Jun. 2023.


AfterNext HealthTech Acquisition Cash Flow from Financing Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Cash Flow from Financing Chart

AfterNext HealthTech Acquisition Annual Data
Trend Dec21 Dec22
Cash Flow from Financing
- -

AfterNext HealthTech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only - - - - -

AfterNext HealthTech Acquisition Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

AfterNext HealthTech Acquisition's Cash from Financing for the fiscal year that ended in Dec. 2022 is calculated as:

AfterNext HealthTech Acquisition's Cash from Financing for the quarter that ended in Jun. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AfterNext HealthTech Acquisition  (NYSE:AFTR) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

AfterNext HealthTech Acquisition's issuance of stock for the three months ended in Jun. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

AfterNext HealthTech Acquisition's repurchase of stock for the three months ended in Jun. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

AfterNext HealthTech Acquisition's net issuance of debt for the three months ended in Jun. 2023 was $0.00 Mil. AfterNext HealthTech Acquisition received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

AfterNext HealthTech Acquisition's net issuance of preferred for the three months ended in Jun. 2023 was $0.00 Mil. AfterNext HealthTech Acquisition paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

AfterNext HealthTech Acquisition's cash flow for dividends for the three months ended in Jun. 2023 was $0.00 Mil. AfterNext HealthTech Acquisition received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

AfterNext HealthTech Acquisition's other financing for the three months ended in Jun. 2023 was $0.00 Mil. AfterNext HealthTech Acquisition received $0.00 Mil on other financial activities.


AfterNext HealthTech Acquisition Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102
Website
AfterNext HealthTech Acquisition Corp is a blank check company.
Executives
Jon Winkelried director, 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise director, officer: Chief Executive Officer 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc. director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter director 500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson officer: Chief Financial Officer C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca director, officer: President MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller director 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein director C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines